Wide Open Agriculture Limited (ASX: WOA) is an Australian ingredient company focused on plant-based proteins, notably lupin protein isolates. The company has been developing its presence in the global market, targeting food and beverage manufacturers that require sustainable and functional plant proteins. While the financial impact of recent sales is not significant, these orders mark an essential step in WOA’s commercialisation efforts.
WOA has successfully secured commercial sales for over 5 metric tonnes of its lupin protein isolate, signaling an increase in demand for alternative plant-based proteins.
These orders span multiple regions, including Europe, Latin America, and Australia, highlighting the company’s growing international footprint.
One of the major orders comes from Tarwi, a European health food company, which plans to launch a reformulated protein powder incorporating WOA’s lupin protein. The partnership is expected to leverage Tarwi’s existing consumer base of over 30,000 followers on Instagram and expand WOA’s exposure in the European market.
Additional sales have been made to ingredient distributors in Mexico, Argentina, Chile, and Australia, further validating the global appeal of WOA’s products.
Customer feedback has played a crucial role in WOA’s growing reputation. Endorsements from partners highlight the protein’s neutral taste, superior functionality, and sustainability benefits. The company believes these initial sales will help it overcome one of the biggest barriers in the food industry—the long commercialisation cycle for new ingredients.
Beyond current sales, WOA is actively negotiating with distributors and food brands in China, North America, Korea, and Australia. These discussions indicate potential for further market penetration and long-term growth.
Over the past 12–18 months, WOA has been building a global database of sales leads, which the company aims to convert into lasting partnerships.
Looking ahead, WOA is focused on strengthening relationships with existing customers to secure repeat orders and increase production efficiency.
The company remains committed to positioning its lupin protein as a premium plant-based ingredient while continuing to explore new sales opportunities in Asia and beyond.
Chifley Tower, 2 Chifley Square,
Sydney NSW 2000
1300 854 151
© 2023 KOSEC | Kodari Securities Pty Ltd | ABN 90 147 963 755 | FSG | Terms & Conditions | Disclaimer & Legal
© 2023 KOSEC | Kodari Securities Pty Ltd
ABN 90 147 963 755
KOSEC - Kodari Securities does not provide any investment advice, nor is anything mentioned an offer to sell, or a solicitation of an offer to buy any security or other instrument. Anything discussed is for informational purposes only and does not address the circumstances or needs of any particular individual or entity. Investing in the stock market is high risk. Under no circumstances should investments be based solely on the information provided. We do not guarantee the security or completeness of information on this website and are not held liable. Kodari Securities PTY Ltd trading as KOSEC is a corporate authorized representative (AFSL no.246638) which is regulated by the Australian securities and investment commission (ASIC).
